Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.
Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S.
Crit Rev Microbiol. 2016 Nov;42(6):905-27. doi: 10.3109/1040841X.2015.1091805. Epub 2015 Dec 21.
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
MacAlpine J, Lionakis MS.
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
Basic Research on Candida Species.
Abe M, Kinjo Y, Koshikawa T, Miyazaki Y.
Med Mycol J. 2024;65(3):67-74. doi: 10.3314/mmj.24.006.
Immunity to Candida.
Fidel PL Jr.
Oral Dis. 2002;8 Suppl 2:69-75. doi: 10.1034/j.1601-0825.2002.00015.x.
Recurrent vulvovaginal candidiasis.
Lines A, Vardi-Flynn I, Searle C.
BMJ. 2020 Jun 8;369:m1995. doi: 10.1136/bmj.m1995.
Candida vulvovaginitis.
Sobel JD.
Semin Dermatol. 1996 Mar;15(1):17-28. doi: 10.1016/s1085-5629(96)80014-9.
Biofilms and vulvovaginal candidiasis.
Rodríguez-Cerdeira C, Gregorio MC, Molares-Vila A, López-Barcenas A, Fabbrocini G, Bardhi B, Sinani A, Sánchez-Blanco E, Arenas-Guzmán R, Hernandez-Castro R.
Colloids Surf B Biointerfaces. 2019 Feb 1;174:110-125. doi: 10.1016/j.colsurfb.2018.11.011. Epub 2018 Nov 7.
Mycology of vulvovaginitis.
Robertson WH.
Am J Obstet Gynecol. 1988 Apr;158(4):989-91. doi: 10.1016/0002-9378(88)90109-3.
Pathophysiology of vulvovaginal candidiasis.
Sobel JD.
J Reprod Med. 1989 Aug;34(8 Suppl):572-9; discussion 579-80.
Determining Susceptibility in Candida Vaginal Isolates.
Sobel JD, Akins R.
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0236621. doi: 10.1128/aac.02366-21. Epub 2022 May 23.
